DPD

(redirected from Deoxypyridinoline)
Also found in: Medical.
AcronymDefinition
DPDDepartment of Planning and Development
DPDDevelopment Plan Document (UK)
DPDDallas Police Department (Dallas, TX)
DPDDead Peer Detection (Cisco)
DPDDihydropyrimidine Dehydrogenase
DPDDivision of Parasitic Diseases (US CDC)
DPDDenver Police Department
DPDDetroit Police Department
DPDDeoxypyridinoline
DPDDominant Wave Period
DPDDrug Product Database
DPDDiccionario Panhispánico de Dudas (Spanish)
DPDDigital Pre-Distortion
DPDDeutscher Paketdienst (Germany)
DPDDependent Personality Disorder
DPDDirect Parcel Distribution (European logistics service)
DPDDirection de la Programmation et du Développement (French: Department of Programming and Development; French Ministry of Education, Youth and the Voluntary Sector)
DPDDepersonalization Disorder
DPDDewan Pimpinan Daerah (Indonesian: Regional Leaders Council)
DPDDangerous Preparations Directive
DPDDigital Product Definition
DPDDifferential Phase Detection
DPDDayton Police Department (Ohio)
DPDDiver Propulsion Device
DPDData Processing Department
DPDN,n-Diethyl-P-Phenylene-Diamine
DPDDiploma in Practical Dermatology (UK)
DPDDead Piro Day (MegaTokyo comic)
DPDDistributed Product Description (Modeling and Simulation; Simulation Based Acquisition)
DPDData Processing Design
DPDDefense Programming Database
DPDDrejtoria e Përgjithshme e Doganave (Albanian: General Directorate of Dutys)
DPDDeutscher Pressedienst
DPDDegree Programme Director (Newcastle University; UK)
DPDDay Past Due
DPDDriver/Pre-Driver
DPDData Project Description
DPDData Project Directive
DPDDigital Product Description
DPDDignitary Protection Division (United States Capitol Police)
DPDDumas Police Department (Dumas, Texas)
DPDDigital Publications Development Program (US Army ASRL)
DPDDuty Paid Delivered
DPDDetailed Product Document
DPDDetailed Procedural Design (software development)
DPDData Product Definition (Logistics Management Information)
DPDDependability of Physical Design
DPDDry Packaged Dessert
DPDDesign Proposal Drawings
DPDDivisión de Prevención del Delito (Spanish: Crime Prevention Division; Guatemala)
DPDDynamic Parcel Distribution (UK)
DPDDémarginalisation des Pauvres par le Droit (French: Empowerment of the Poor; Bénin)
DPDDigital Photo Display
DPDDekart Private Disk (encryption software)
DPDDistribution Produits Déco (French: Home Products Distribution)
DPDDemos Pra Download (music blog)
References in periodicals archive ?
In contrast to the weak activity of PE on improving the bone formation biomarkers, PE exhibited great potential in suppressing the bone resorption markers, including tartrate-resistant acid phosphatase (TRAP), cathepsin K and deoxypyridinoline crosslinks (DPD).
Increasing urinary cadmium, but not serum retinol, was associated with increases in deoxypyridinoline and decreases in parathyroid hormone concentrations, which indicates the effect of cadmium on bone turnover and increased bone resorption.
Furthermore, urinary cadmium was negatively associated with parathyroid hormone (a bone metabolism hormone) and positively associated with urinary deoxypyridinoline (a bone resorption marker).
A subset of 520 women had biochemical markers of bone turnover (serum bone-specific alkaline phosphatase [BSAP], serum carboxy-terminal extension peptide of procollagen type 1 [PICP], urinary N-terminal telopeptide [NTX and urinary free deoxypyridinoline [DPD]) measured at baseline.
Two bone markers were measured: bone-specific alkaline phosphatase (BSAP) and deoxypyridinoline (DPD).
Markers of bone turnover include bone-specific alkaline phosphatase, osteocalcin, and the collagen cross-links, deoxypyridinoline, C-telopeptide (CTX), and N-telopeptide (NTX).
How it works: It tests for the presence of a bone breakdown product in the urine called Deoxypyridinoline (Dpd).
Patent Office has allowed two of its 1987 patent applications for deoxypyridinoline (D-Pyr) bone resorption assays.
Daily oral doses of alendronate (5, 20, and 40 mg for six weeks) in postmenopausal women produced biochemical changes indicative of dose-dependent inhibition of bone resorption, including decreases in urinary calcium and urinary markers of bone collagen degradation (such as deoxypyridinoline and cross-linked N-telopeptides of type I collagen).
Serum concentrations of type I collagen C-terminal telopeptide (CTX-I) and cartilage oligomeric matrix protein (COMP) and urinary concentrations of deoxypyridinoline (DPD) were measured, and disease severity was assessed.
Serum B2-microglubulin concentration correlates with urinary concentrations of type | collagen cross-linked N-telopeptides and deoxypyridinoline in rheumatoid arthritis.
Serum osteocalcin level was low (68%) and urinary deoxypyridinoline to creatinine ratio was high (79%), which demonstrated low bone formation with high resorption.